about to breakout - get on board now, page-104

re: sirtex breakout to 3.80 near According to current US biotech valuations a co with a market value like Sirtex at 80 million USD with a product that has market potential in the 5-8 Billion USD range at only a modest 7 % penetrance of 350-560 million in sales at 20 % net margin has profit potential at only 7 % penetrance of 1.27-2.03 USD which is a P.E of about 1 with > 50 % growth . HH says its original model was 19 dollars a share and this may explain its aggressiveness. It takes 7-10 years to develop new oncology producys and this is why many times acquisition is much cheaper to gain competitive advantage in the biotech industry.